Mark Emberton

Навело

	Све	Од 2020
Наводи	46590	21426
h-индекс	99	64
i10-индекс	419	302

4700

2350

1175

3525

20032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025133 182 242 496 546 585 686 830 970 1334 1527 2183 2530 2670 2752 2966 3436 3748 4288 4157 3781 4668 755

Јавни приступ

Прикажи све

292 чланка

47 чланака

доступно

није доступно

На основу услова финансирања

Коаутори

Professor Hashim U AhmedProfessor and Chair, Imperial Urology, Imperial College LondonВерификована је имејл адреса на imperial.ac.uk
Professor Caroline M MooreUniversity College LondonВерификована је имејл адреса на ucl.ac.uk
Dean BarrattProfessor of Medical Image Computing, University College LondonВерификована је имејл адреса на ucl.ac.uk
D J HawkesProfessor of Computational Imaging, UCLВерификована је имејл адреса на ucl.ac.uk
Doug PendséHon. Associate ProfessorВерификована је имејл адреса на dougpendse.com
Mike GrocottProfessor of Anaesthesia & Critical Care Medicine, University of Southampton / Duke UniversityВерификована је имејл адреса на soton.ac.uk
Steven JoniauUrologist, University Hospitals LeuvenВерификована је имејл адреса на uzleuven.be
Philippe PUECHProfessor of Radiology, Lille University HospitalВерификована је имејл адреса на dicomworks.com
Jelle BarentszProfessor of Radiology, Chairman Radboud Prostate MRI Expert CenterВерификована је имејл адреса на radboudumc.nl
Stanton NewmanCity University LondonВерификована је имејл адреса на city.ac.uk
Zeike A. TaylorAssociate Professor, University of LeedsВерификована је имејл адреса на leeds.ac.uk
mark hamiltonConsultant and Honorary Senior Lecturer in Anaesthesia and Intensive Care MedicineВерификована је имејл адреса на nhs.net
Matthew R SydesMRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University CollegeВерификована је имејл адреса на ucl.ac.uk
Arash RashidianDirector, Science, Information & Dissemination, WHO EMRO; Professor, School of Public Health, TUMSВерификована је имејл адреса на who.int
Gareth AmblerUniversity College LondonВерификована је имејл адреса на ucl.ac.uk
Joseph L. ChinProfessor of Surgery, Western UniversityВерификована је имејл адреса на lhsc.on.ca
Samuel I WatsonUniversity of BirminghamВерификована је имејл адреса на bham.ac.uk
Denny LevettUniversity of Southampton
Shahrokh F. Shariat, M.D.Department of Urology, Comprehensive Cancer Center, Medical University of Vienna and GeneralВерификована је имејл адреса на meduniwien.ac.at
Jeremy KepnerMIT Lincoln Laboratory Supercomputing CenterВерификована је имејл адреса на ll.mit.edu

Прати

Mark Emberton

Professor of Interventional Oncology, University College London, UK

Верификована је имејл адреса на ucl.ac.uk

Prostate cancer Voiding dissorder imaging trial design


Наслов Сортирај по наводима Сортирај по години Сортирај по наслову	Навело Навело	Година
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study HU Ahmed, AES Bosaily, LC Brown, R Gabe, R Kaplan, MK Parmar, ... The Lancet 389 (10071), 815-822, 2017	3403	2017
MRI-targeted or standard biopsy for prostate-cancer diagnosis V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ... New England Journal of Medicine 378 (19), 1767-1777, 2018	3141	2018
EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction M Oelke, A Bachmann, A Descazeaud, M Emberton, S Gravas, MC Michel, ... European urology 64 (1), 118-140, 2013	1515	2013
Systematic review of complications of prostate biopsy S Loeb, A Vellekoop, HU Ahmed, J Catto, M Emberton, R Nam, ... European urology 64 (6), 876-892, 2013	1278	2013
Can clinically significant prostate cancer be detected with multiparametric magnetic resonance imaging? A systematic review of the literature JJ Fütterer, A Briganti, P De Visschere, M Emberton, G Giannarini, ... European urology 68 (6), 1045-1053, 2015	932	2015
Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting L Dickinson, HU Ahmed, C Allen, JO Barentsz, B Carey, JJ Futterer, ... European urology 59 (4), 477-494, 2011	907	2011
EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines) S Madersbacher, G Alivizatos, J Nordling, CR Sanz, M Emberton, ... European urology 46 (5), 547-554, 2004	893	2004
Early detection of cancer D Crosby, S Bhatia, KM Brindle, LM Coussens, C Dive, M Emberton, ... Science 375 (6586), eaay9040, 2022	731	2022
Image-guided prostate biopsy using magnetic resonance imaging–derived targets: a systematic review CM Moore, NL Robertson, N Arsanious, T Middleton, A Villers, L Klotz, ... European urology 63 (1), 125-140, 2013	693	2013
Detection of clinically significant prostate cancer using magnetic resonance imaging–ultrasound fusion targeted biopsy: a systematic review M Valerio, I Donaldson, M Emberton, B Ehdaie, BA Hadaschik, LS Marks, ... European urology 68 (1), 8-19, 2015	553	2015
Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group CM Moore, V Kasivisvanathan, S Eggener, M Emberton, JJ Fütterer, ... European urology 64 (4), 544-552, 2013	486	2013
Weakly-supervised convolutional neural networks for multimodal image registration Y Hu, M Modat, E Gibson, W Li, N Ghavami, E Bonmati, G Wang, ... Medical image analysis 49, 1-13, 2018	483	2018
Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study HU Ahmed, RG Hindley, L Dickinson, A Freeman, AP Kirkham, M Sahu, ... The lancet oncology 13 (6), 622-632, 2012	460	2012
EAU Guidelines on benign prostatic hyperplasia (BPH) JJ de la Rosette, G Alivizatos, S Madersbacher, M Perachino, D Thomas, ... European urology 40 (3), 256-263, 2001	455	2001
The role of focal therapy in the management of localised prostate cancer: a systematic review M Valerio, HU Ahmed, M Emberton, N Lawrentschuk, M Lazzeri, ... European urology 66 (4), 732-751, 2014	445	2014
How good is MRI at detecting and characterising cancer within the prostate? APS Kirkham, M Emberton, C Allen European urology 50 (6), 1163-1175, 2006	445	2006
Photodynamic therapy for prostate cancer—a review of current status and future promise CM Moore, D Pendse, M Emberton Nature clinical practice Urology 6 (1), 18-30, 2009	396	2009
Is it time to consider a role for MRI before prostate biopsy? HU Ahmed, A Kirkham, M Arya, R Illing, A Freeman, C Allen, M Emberton Nature reviews Clinical oncology 6 (4), 197-206, 2009	391	2009
Benign prostatic hyperplasia: a progressive disease of aging men1 M Emberton, GL Andriole, J De La Rosette, B Djavan, K Hoefner, ... Urology 61 (2), 267-273, 2003	391	2003
Padeliporfin vascular-targeted photodynamic therapy versus active surveillance in men with low-risk prostate cancer (CLIN1001 PCM301): an open-label, phase 3, randomised … AR Azzouzi, S Vincendeau, E Barret, A Cicco, F Kleinclauss, ... The Lancet Oncology 18 (2), 181-191, 2017	378	2017

Систем тренутно не може да изврши ову радњу. Пробајте поново касније.

Чланци 1–20

Годишњи број навода

Дупли наводи

Обједињени наводи

Додавање коаутораКоаутори

Прати

Навело

Коаутори